<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02335996</url>
  </required_header>
  <id_info>
    <org_study_id>2014-23</org_study_id>
    <secondary_id>2014-A01302-45</secondary_id>
    <secondary_id>RCAPHM14_0343</secondary_id>
    <nct_id>NCT02335996</nct_id>
  </id_info>
  <brief_title>Hypercortisolism and Epicardial Adipose Tissue</brief_title>
  <acronym>Hyper-Cor</acronym>
  <official_title>Impact Hypercortisolism on Adipose Epicardial and on Myocardial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identifying hypercortisolism patients at risk for cardio-vascular events despite biological
      cure, and determine which patients should be particularly followed. Hypercortisolic patients
      represent an ideal in vivo model to determine the interactions between glucocorticoids and
      ectopic fat development.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measuring the volume of epicardial adipose tissue, as measured by MRI to 3 Tesla.</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess insulin resistance by the blood sugar and insulin levels</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess cardiovascular risk by a blood complete lipid profile</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess insulin resistance by the blood leptin, adiponectin and omentin plasma level</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess cardiovascular risk by the blood leptin, adiponectin and omentin plasma level</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Hypercortisolism</condition>
  <arm_group>
    <arm_group_label>patients with active hypercortisolism</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients in remission of their hypercortisolism after surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood samples for measuring adiponectin, leptin and omentin plasma</intervention_name>
    <arm_group_label>patients with active hypercortisolism</arm_group_label>
    <arm_group_label>Patients in remission of their hypercortisolism after surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI at 3 Tesla</intervention_name>
    <description>Evaluation by MRI at 3 Tesla of the amount of ectopic fat heart, liver and pancréas and bone marrow.</description>
    <arm_group_label>patients with active hypercortisolism</arm_group_label>
    <arm_group_label>Patients in remission of their hypercortisolism after surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major, male or female

          -  Introducing an active or healed hypercortisolism caused by Cushing's disease

          -  signed informed consent.

        Exclusion Criteria:

          -  Elderly patients under 18 years

          -  Pregnant or lactating women

          -  Previous history of myocardial infarction

          -  Antecedent congenital cardiomyopathy

          -  Adrenocorticotropic hormone-independent Hyperadrenocorticism

          -  Hyperadrenocorticism by ectopic Adrenocorticotropic hormone secretion

          -  Treatment with corticosteroids or insulin

          -  Specific contraindication to the achievement of Nuclear Magnetic Resonance (metal
             heart valves, pacemakers, metallic foreign body, claustrophobia)

          -  Persons deprived of liberty

          -  Persons not affiliated to a social security scheme

          -  People unable to give their consent in writing (in person or with the assistance of a
             third party).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle DESALBRES, Director</last_name>
    <role>Study Director</role>
    <affiliation>Asistance Publique Hôpitaux Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frederic CASTINETTI, CCA</last_name>
    <phone>04.91.38.65.97</phone>
    <email>frederic.castinetti@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Urielle DESALBRES, Director</last_name>
      <phone>04.91.38.27.47</phone>
      <email>drci@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2015</study_first_submitted>
  <study_first_submitted_qc>January 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2015</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cushing Syndrome</mesh_term>
    <mesh_term>Adrenocortical Hyperfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

